Africa CDC: Establishing Integrated Surveillance and Laboratory Networks for Rapid Disease Detection and Response, Control, Prevention, and Clinical Care in Africa

Africa CDC establishing integrated-surveillance laboratory networks
  • Version
  • Download 2248
  • File Size 2.04 MB
  • File Count 1
  • Create Date 30 January 2019
  • Last Updated 9 September 2019

Africa CDC: Establishing Integrated Surveillance and Laboratory Networks for Rapid Disease Detection and Response, Control, Prevention, and Clinical Care in Africa

There is little similarity between asbestos, HIV, and the severe acute respiratory syndrome coronavirus. However, their histories illustrate the three keys for effective detection and control of disease: clinical identification, laboratory detection, and public response. In diseases where all elements of this three-step framework were in place, the time from initial observation to appropriate public response tended to occur quickly. For example, in late November 2002, an atypical pneumonia that ultimately came to be known as severe acute respiratory syndrome made its appearance in China and a few other countries in East Asia. Once the World Health Organization was notified in February 2003, a massive coordinated response was deployed. The causative agent was identified within two weeks and the disease was halted by effective quarantine in 42 days.

Attached Files

FileAction
Africa CDC establishing integrated surveillance laboratory networksDownload

This slide deck, presented at the Developing Countries Vaccine Manufacturers Network International Annual General Meeting in October 2024, describes updated results from a study to assess the current and planned state of vaccine manufacturing in Africa and provides insights into what’s needed to develop a robust and sustainable vaccine manufacturing ecosystem.

We surveyed African vaccine manufacturers to better understand their current manufacturing capacity and capabilities, the progress they’ve made since 2023, and their future outlooks. This information can help stakeholders and funders better coordinate and prioritize actions to build a successful African vaccine manufacturing ecosystem.

Corporate author(s): Africa Centres for Disease Control and Prevention (Africa CDC); Clinton Health Access Initiative (CHAI); PATH

Publication date: October 2024

Download Files
FileAction
African Vaccine Manufacturing Mapping | Supply and Demand LandscapeDownload